
CellType YC Application
CellType went through Y Combinator in the Winter 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2026
- Industry
- HealthcareDrug Discovery and Delivery
- Team size
- 2
- Status
- Active
- Launched
- 2026
Founders
David van DijkCo-Founder & CEO
Ivan VrkicCo-Founder
What CellType does
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
CellType's YC application, reconstructed
Y Combinator application
CellType, Winter 2026 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
CellType
The agentic drug company. We simulate human biology.
We are building AI agents that run the entire drug discovery pipeline on top of biological foundation models that simulate human biology. Our platform can predict how drugs interact with biological systems, enabling us to discover new treatments faster and more reliably than traditional methods. We've already found and validated a new cancer treatment signal using this tech.
We live and work in New York City, and after YC, CellType will remain based here.
New York City has the biotech ecosystem and pharma partners we need close by. We can recruit scientists and engineers here and maintain strong relationships with top pharma companies already collaborating with us.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real CellType YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from CellType's public data (launch notes, founder backgrounds, product description). It shows how a company like CellType would present itself to YC, not the text they submitted.
What YC batch was CellType in?
CellType was part of the Y Combinator Winter 2026 batch.
Who founded CellType?
CellType was founded by David van Dijk, Ivan Vrkic.
What does CellType do?
The agentic drug company. We simulate human biology.
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of CellType's application, and every other YC batch, is in YC Insights.